A Phase 1/2 Trial of TH-302 and Dexamethasone with Bortezomib (TBorD) in Patients with Relapsed/Refractory Multiple MyelomaJacob P Laubach,Philippe Armand,Jacalyn Rosenblatt, Jacquelyn Hedlund,Craig Reynolds,Ira Zackon, Laura Stampleman,Stacey Chuma, Rebecca Liguori,Damian Handisides,Stew Krollmag(2014)引用 23|浏览12暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要